TP53 and neoplasm: Cervical cancer associated with HPV uses viral oncogene-mediated inactivation of the tumor suppressor genes TP53 and RB1 as the primary driver, while HPV-independent tumors use different patterns of somatic mutations that activate distinct oncogenic pathways leading to tumor advancement [58].